IDEXX LABORATORIES INC /DE - Common Stock (IDXX)

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock
Shares outstanding: 80,841,255
Number of holders: 1,021
Total 13F shares, excl. options: 72,890,084
Shares change: +180,849
Total reported value, excl. options: $46,029,916,801
Value change: +$144,499,493
Put/Call ratio: 152%
Number of buys: 423
Number of sells: -445
Price: $631.55

Significant Holders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) as of Q2 2021

1,114 filings reported holding IDXX - IDEXX LABORATORIES INC /DE - Common Stock as of Q2 2021.
IDEXX LABORATORIES INC /DE - Common Stock (IDXX) has 1,021 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 72,890,084 shares of 80,841,255 outstanding shares and own 90.16% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (9,065,541 shares), BlackRock Inc. (8,274,891 shares), Fundsmith LLP (4,242,462 shares), STATE STREET CORP (3,629,537 shares), BAMCO INC /NY/ (2,696,326 shares), GEODE CAPITAL MANAGEMENT, LLC (1,711,457 shares), BLAIR WILLIAM & CO/IL (1,349,965 shares), FRANKLIN RESOURCES INC (1,305,965 shares), BANK OF AMERICA CORP /DE/ (1,243,936 shares), and ALLIANCEBERNSTEIN L.P. (1,231,970 shares).
This table shows the top 1021 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.